WPL06910 - Peritoneal Malignancy Outsourcing - Elective CRS and HIPEC
HAMPSHIRE HOSPITALS NHS FOUNDATION TRUST
- Value
- Not stated
- Published
- 17 Sept 2026
- Deadline
- Not stated
- Procedure
- Not stated
- Category
- 85111000 — Hospital services
- Location
- UKI
- Notice reference
- 088141-2026
Requirements summary
Hampshire Hospitals NHS Foundation Trust is planning to procure a qualified sub-contractor to provide specialised Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) capacity for patients with Pseudomyxoma Peritonei and Colorectal Peritoneal Metastases. The service is a consultant-led, integrated tertiary care sub-contract covering the full pathway from pre-operative assessment to discharge. The notice is a planned intended-approach notice under the Provider Selection Regime, with expressions of interest due by 23:59 on 1 October 2026.
Key requirements
- Qualified sub-contractor providing CRS and HIPEC surgical capacity
- Care for patients with Pseudomyxoma Peritonei (PMP) and Colorectal Peritoneal Metastases (CPM)
- Consultant-led, fully integrated tertiary care with end-to-end pathway delivery
- Pathway to include pre-operative assessment, surgery, Level 2/3 critical care, inpatient ward care and discharge management
- Lot 1: site accessibility via major transport hubs, with London support networks, for regions UKI and UKJ
- Lot 2: dedicated on-site or partnered accommodation for patient relatives in UKJ, including out-of-region patients